Quick Answer
Pulmatrix, Inc. reported Earnings Per Share Diluted of $1.41 (loss) per share for the year ending 2025.
- Pulmatrix, Inc. showed an increase of +46.2% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Pulmatrix, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2022: $1.36 (loss) per share | Q3 2022: $1.45 (loss) per share | Q1 2023: $1.22 (loss) per share | Q2 2023: $1.04 (loss) per share | Q3 2023: $1.03 (loss) per share | Q1 2024: $0.23 per share | Q2 2024: $1.59 (loss) per share | Q3 2024: $0.71 (loss) per share | Q1 2025: $0.50 per share | Q2 2025: $0.42 (loss) per share | Q3 2025: $0.24 (loss) per share.
- Over the full 4 years of available data (2022 to 2025), Pulmatrix, Inc.'s Earnings Per Share Diluted has grown by 74.2%.
- Historical annual values: Fiscal year 2025: $1.41 (loss) per share | Fiscal year 2024: $2.62 (loss) per share | Fiscal year 2023: $3.87 (loss) per share | Fiscal year 2022: $5.46 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: